TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.

A A Chiappori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.